Frontiers in Immunology

ISSN: 1664-3224
Publisher: Frontiers Research Foundation / Frontiers Media

Publications (320)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Silent neonatal influenza A virus infection primes systemic antimicrobial immunity (2023) Heinemann AS, Stalp JL, Bonifacio JPP, Silva F, Willers M, Heckmann J, Fehlhaber B, et al. Journal article Nr4a1-dependent non-classical monocytes are important for macrophage-mediated wound healing in the large intestine (2023) Heidbreder K, Sommer K, Wiendl M, Müller T, Atreya I, Hildner K, Neurath M, Zundler S Journal article Editorial: Effector functions of therapeutic antibodies (2023) Boross P, Peipp M, Nimmerjahn F Journal article The future of affordable cancer immunotherapy (2023) Schaft N, Dörrie J, Schuler G, Schuler-Thurner B, Sallam H, Klein S, Eisenberg G, et al. Journal article, Review article Novel T cell/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease (2023) Matthe D, Dinkel M, Schmid B, Vogler T, Neurath M, Poeck H, Neufert C, et al. Journal article Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionality. (2023) Pfister F, Dörrie J, Schaft N, Buchele V, Unterweger H, Carnell LR, Schreier P, et al. Journal article Suppression of neutrophils by sodium exacerbates oxidative stress and arthritis (2023) Zlatar L, Mahajan A, Munoz Becerra M, Weidner D, Bila G, Bilyy R, Titze J, et al. Journal article Breaking bad: necroptosis in the pathogenesis of gastrointestinal diseases (2023) Patankar J, Bubeck M, Gonzalez Acera M, Becker C Journal article, Review article Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma (2023) Daunke T, Beckinger S, Rahn S, Krüger S, Heckl S, Schäfer H, Wesch D, et al. Journal article Multimodal analysis of granulocytes, monocytes, and platelets in patients with cystic fibrosis before and after Elexacaftor–Tezacaftor–Ivacaftor treatment (2023) Schmidt H, Höpfer LM, Wohlgemuth L, Knapp CL, Mohamed AOK, Stukan L, Münnich F, et al. Journal article